University of Alabama Hospital

Birmingham, Alabama 35294

13 studies enrolling now · 39 studies all time

What they study most

ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Ischemic Stroke, Acute Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Failure, Alzheimer's Disease, Atrial Fibrillation, CPAP, Cardiac Arrest, Out-Of-Hospital, Chronic Hand Eczema (CHE), Chronic Heart Failure

Studies at this site

• JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart — Recruiting now
• JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab — Recruiting now
• JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) — Recruiting now
• JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab — Recruiting now
• Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging — Recruiting now
• Strategy for Improving Stroke Treatment Response — Recruiting now
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
• StrokeNet Thrombectomy Endovascular Platform — Recruiting now
• Screening for AL Amyloidosis in Smoldering Multiple Myeloma — Recruiting now
• Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis — Running, not enrolling
• HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP — Enrolling by invitation
• Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients — Completed
• Effect of Ketamine and Etomidate During RSI on Long Term Outcomes — Enrolling by invitation
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma — Running, not enrolling
• The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study — Completed
• Sleep for Stroke Management and Recovery Trial — Running, not enrolling
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
• Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP — Completed
• Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors — Running, not enrolling
• Tube Size Randomized Trial During Emergency Tracheal Intubation — Enrolling by invitation
• Multi-arm Optimization of Stroke Thrombolysis — Completed
• A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) — Status unconfirmed
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2 — Withdrawn before enrolling
• A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma — Stopped early
• Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure — Completed
• Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis — Completed
• PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel — Completed
• PROMComplete for Determination of Rupture of Fetal Membranes — Status unconfirmed
• The Intravascular Cooling in the Treatment of Stroke 2/3 Trial — Stopped early
• Safety Study of External Counterpulsation as a Treatment for Acute Ischemic Stroke — Completed
• Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Safety Study of Ivacaftor in Subjects With Cystic Fibrosis — Completed
• Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase — Stopped early
• Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture — Completed
• Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts — Completed
• Safety & Efficacy of ALT-711 (Alagebrium) in Chronic Heart Failure — Stopped early